Reshaping [99mTc]Tc-DT11 to DT14D Tagged with Trivalent Radiometals for NTS1R-Positive Cancer Theranostics
Open Access
- 28 February 2025
- journal article
- research article
- Published by MDPI AG in Pharmaceutics
- Vol. 17 (3) , 310
Abstract
Background/Objectives: Radiotheranostics of neurotensin subtype 1 receptor (NTS1R)-expressing tumors, like pancreatic, gastrointestinal, or prostate cancer, has attracted considerable attention in recent years. Still, the fast degradation of neurotensin (NT)-based radioligands, by angiotensin-converting enzyme (ACE), neprilysin (NEP), and other proteases, has considerably compromised their efficacy. The recently introduced [99mTc]Tc-DT11 (DT11, N4-Lys(MPBA-PEG4)-Arg-Arg-Pro-Tyr-Ile-Leu-OH; N4, 6-(carboxy)-1,4,8,11-tetraazaundecane) has displayed promising uptake in NTS1R-positive tumors in mice and enhanced resistance to both ACE and NEP by virtue of the lateral MPBA-PEG4 (MPBA, 4-(4-methylphenyl)butyric acid; PEG4, 14-amino-3,6,9,12-tetraoxatetradecan-1-oic acid) chain attached to the ε-NH2 of Lys7. We were next interested in investigating whether these qualities could be retained in DT14D, likewise modified at Lys7 but carrying the universal chelator DOTA (1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid) via a (βAla)3 spacer at the α-NH2 of Lys7. This chelator switch enables the labeling of DT14D with a wide range of trivalent radiometals suitable for true theranostic applications, not restricted to the diagnostic imaging of NTS1R-positive lesions only by single-photon emission computed tomography (SPECT). Methods: DT14D was labeled with Ga-67 (a surrogate for the positron emission tomography radionuclide Ga-68), In-111 (for SPECT), and Lu-177 (applied in radiotherapy). The resulting radioligands were tested in NTS1R-expressing pancreatic cancer AsPC-1 cells and mice models. Results: [67Ga]Ga/[111In]In/[177Lu]Lu-DT14D displayed high affinity for human NTS1R and internalization in AsPC-1 cells. They remained >70% intact 5 min after entering the mice’s circulation, displaying NTS1R-specific uptake in AsPC-1 xenografts. Conclusions: Suitably side-chain modified NT analogs show enhanced metabolic stability and hence better prospects for radiotheranostic application in NTS1R-positive cancer.Keywords
This publication has 65 references indexed in Scilit:
- Chelator boosted tumor-retention and pharmacokinetic properties: development of 64Cu labeled radiopharmaceuticals targeting neurotensin receptorEuropean Journal of Nuclear Medicine and Molecular Imaging, 2024
- Re‐thinking the role of radiometal isotopes: Towards a future concept for theranostic radiopharmaceuticalsJournal of Labelled Compounds and Radiopharmaceuticals, 2017
- In Silico Investigation of the Neurotensin Receptor 1 Binding Site: Overlapping Binding Modes for Small Molecule Antagonists and the Endogenous Peptide AgonistMolecular Informatics, 2015
- Syntheses, Receptor Bindings, in vitro and in vivo Stabilities and Biodistributions of DOTA‐Neurotensin(8–13) Derivatives Containing β‐Amino Acid Residues – A Lesson about the Importance of Animal ExperimentsChemistry & Biodiversity, 2013
- Introduction of lipidization–cationization motifs affords systemically bioavailable neuropeptide Y and neurotensin analogs with anticonvulsant activitiesJournal of Peptide Science, 2010
- [99mTc]Demotensin 5 and 6 in the NTS1-R-targeted imaging of tumours: synthesis and preclinical resultsEuropean Journal of Nuclear Medicine and Molecular Imaging, 2007
- Stabilised 111In-labelled DTPA- and DOTA-conjugated neurotensin analogues for imaging and therapy of exocrine pancreatic cancerEuropean Journal of Nuclear Medicine and Molecular Imaging, 2003
- Structure of human neutral endopeptidase (neprilysin) complexed with phosphoramidon 1 1Edited by R. HuberJournal of Molecular Biology, 2000
- Neurotensin receptors in human neoplasms: High incidence in Ewing's sarcomasInternational Journal of Cancer, 1999
- Neurotensin Receptor and Its mRNA Are Expressed in Many Human Colon Cancer Cell Lines But Not in Normal Colonic Epithelium: Binding Studies and RT-PCR ExperimentsBiochemical and Biophysical Research Communications, 1994